(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine, 97%, 10g

3-Nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 98%, 1g

(E)-Ethyl 4,4-dimethoxybut-2-enoate, 95.0%, 10g

Volumetric flasks with glass stopper, class A Brown glass, 500 ml, 19/26, 2 Piece(s)

7-Hydroxy-4(2-pyridinyl)coumarin, 95.0%, 5g

7-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)heptanoic acid, 98.0%, 1g

3-Chloro-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97%, 1g

Sodium 2-((2-amino-2-oxoethyl)(carboxymethyl)amino)acetate, 95.0%, 100g

Allyl Phenyl Ether>95.0%(GC)25g

(R)-Octahydropyrrolo[1,2-a]pyrazine dihydrochloride, 95.0%, 1g

1-(4,6-Dichloropyridin-2-yl)ethanone, 97.0%, 1g

2-Methyl-5-nitrophenyl isothiocyanate, 98.0%, 5g

2,2-Dimethyl-4,7-dihydro-1,3-dioxepine, 95.0%, 5g